AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Explore effective ways to earn money with side jobs now. Choose options that fit your lifestyle and start today.
22,363 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Investors often chase the 'smartest' stock, but in defense, the best move is a disciplined plan. This article breaks ...
Imagine a SpaceX-scale IPO changing how investors price AI startups. This article breaks down what spacex just bigges...
As AI reshapes how consumers discover and buy, CMOs are expanding beyond brand storytelling to lead growth, data, and...
A legendary macro investor who warned about the 2008 bubble has sold Alphabet and moved into AI hardware names, signa...
Five Eyes partners warn that AI could outpace current cyber defenses, posing a risk to personal finances. This report...
NAR’s board maintained 2027 dues at $156 per member and kicked a proposed ethics Standard of Practice back to committ...
A high-profile Ethereum MEV exploit tied to the Jaredfromsubway bot has seen the attacker move millions via Tornado C...
Bitcoin hovers near a pivotal zone as bulls and bears clash. Analysts warn of a potential break below key supports, s...
Ray Dalio wraps a 10-day China-focused Asia tour, warning that a realignment of global power could reshape markets an...
A global AI buildout is hitting the power spine, driving a 300% pricing surge for gas turbines. GE Vernova faces a pi...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...